['systemic sclerosis', 'scleroderma', 'interstitial lung disease']
['mycophenolate mofetil', 'placebo']

        Inclusion Criteria:

          1. Patients of systemic sclerosis with presence of interstitial lung disease on High
             Resolution Computer Tomography (HRCT) chest

          2. FVC ≥ 70% of predicted on pulmonary function tests

          3. Age ≥18 years

          4. Consenting for participating in study

        Exclusion Criteria:

          1. Received immunosuppression (except low dose steroids, prednisolone equivalent ≤10
             mg/day) for ILD in the last 3 years

          2. Persistent leucopenia or thrombocytopenia

          3. Pregnant or breastfeeding females

          4. Severe pulmonary arterial hypertension (mean pulmonary arterial pressure >55mmHg)
             requiring drug therapy

          5. Uncontrolled congestive heart failure

          6. Any other abnormalities noted on chest X-ray or HRCT other than ILD

          7. Active infection

          8. Inflammatory myositis

          9. Overlap syndrome

         10. Mixed connective tissue disease

         11. Other serious co-morbidities which could compromise patient's ability to complete the
             study
      